Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14279/19441
Title: | Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper | Authors: | Hill, Loreena Michelle Prager Geller, Tal Baruah, Resham Beattie, James M. Boyne, Josiane J.J. De Stoutz, Noémi D. Di Stolfo, Giuseppe Lambrinou, Ekaterini Skibelund, Anne K. Uchmanowicz, Izabella Rutten, Frans Hendrik Čelutkienė, Jelena Piepoli, Massimo F. Jankowska, Ewa Anita Chioncel, Ovidiu Ben-Gal, Tuvia Seferovíc, Petar M. Ruschitzka, Frank T. Coats, Andrew J.S. Strömberg, Anna E. Jaarsma, Tiny |
Major Field of Science: | Medical and Health Sciences | Field Category: | Clinical Medicine | Keywords: | Clinical guidance;Heart failure;Palliative care | Issue Date: | 2020 | Source: | European Journal of Heart Failure, 2020, vol. 22, no.12, pp. 2327-2339 | Volume: | 22 | Issue: | 12 | Start page: | 2327 | End page: | 2339 | Journal: | European Journal of Heart Failure | Abstract: | The Heart Failure Association of the European Society of Cardiology has published a previous position paper and various guidelines over the past decade recognizing the value of palliative care for those affected by this burdensome condition. Integrating palliative care into evidence-based heart failure management remains challenging for many professionals, as it includes the identification of palliative care needs, symptom control, adjustment of drug and device therapy, advance care planning, family and informal caregiver support, and trying to ensure a 'good death'. This new position paper aims to provide day-to-day practical clinical guidance on these topics, supporting the coordinated provision of palliation strategies as goals of care fluctuate along the heart failure disease trajectory. The specific components of palliative care for symptom alleviation, spiritual and psychosocial support, and the appropriate modification of guideline-directed treatment protocols, including drug deprescription and device deactivation, are described for the chronic, crisis and terminal phases of heart failure. | URI: | https://hdl.handle.net/20.500.14279/19441 | ISSN: | 18790844 | DOI: | 10.1002/ejhf.1994 | Rights: | © The Authors. | Type: | Article | Affiliation : | Queen’s University Belfast Rabin Medical Center Chelsea and Westminster NHS Foundation Trust King's College London Maastricht University Medical Centre ESC Patient Forum Representative Fondazione IRCCS Casa Sollievo della Sofferenza Cyprus University of Technology Wroclaw Medical University University Hospital, Wroclaw Utrecht University Vilnius University Guglielmo da Saliceto Hospital University of Parma Wroclaw Medical University Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’ Carol Davila University of Medicine and Pharmacy Tel Aviv University University Hospital Zurich IRCCS San Raffaele Pisana Linköping University University Medical Center Utrecht |
Publication Type: | Peer Reviewed |
Appears in Collections: | Άρθρα/Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ejhf.1994.pdf | Fulltext | 3.05 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
85
checked on Mar 14, 2024
WEB OF SCIENCETM
Citations
73
Last Week
0
0
Last month
2
2
checked on Oct 29, 2023
Page view(s)
338
Last Week
0
0
Last month
4
4
checked on Nov 6, 2024
Download(s)
340
checked on Nov 6, 2024
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License